Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30567630 | 1.00 | HTT (0.30) | HTT | |
| SCHEMBL29268198 | 0.91 | POLB (0.33) | — | |
| SCHEMBL29989128 | 0.91 | POLB (0.33) | — | |
| SCHEMBL29268201 | 0.91 | POLB (0.33) | — | |
| SCHEMBL30567602 | 0.87 | — | — | |
| SCHEMBL29988593 | 0.87 | — | — | |
| SCHEMBL29988741 | 0.87 | — | — | |
| SCHEMBL29268082 | 0.84 | MAOB (0.33) | — | |
| SCHEMBL29988510 | 0.84 | MAOB (0.33) | — | |
| SCHEMBL29268076 | 0.84 | MAOB (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4611744-A1 | METHODS OF REDUCING MIRO1 OR PHOSPHORYLATED ALPHA-SYNUCLEIN | Acurex Biosciences Corporation (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097632-A1 | METHODS OF REDUCING MIRO1 OR PHOSPHORYLATED ALPHA-SYNUCLEIN | ACUREX BIOSCIENCES CORPORATION (US) | 2024-05-10 | — | — | WO | disclosed |
| WO-2024081653-A2 | METHODS OF LOWERING MIRO2 TO TREAT NEURODEGENERATIVE DISEASES | ACUREX BIOSCIENCES CORPORATION (US) | 2024-04-18 | — | — | WO | disclosed |
| EP-4301759-A2 | T-TYPE CALCIUM CHANNEL ANTAGONISTS AND USES THEREOF | The Board of Trustees of the Leland Stanford Junior University (US) | 2024-01-10 | — | — | EP | disclosed |
| WO-2022216386-A9 | T-TYPE CALCIUM CHANNEL ANTAGONISTS AND USES THEREOF | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2022-12-01 | — | — | WO | disclosed |
| WO-2022216386-A2 | T-TYPE CALCIUM CHANNEL ANTAGONISTS AND USES THEREOF | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2022-10-13 | — | — | WO | disclosed |